NAT treated patients showed elevated eosinophil (p = 0.003) and basophil (p = 0.002) counts compared to untreated MS patients while IFN treated patients showed a trend towards reduced neutrophil counts (p = 0.054). Here, IFNA1 is linked to myeloid sarcoma.